Review of Asian experience of thermal ablation techniques and clinical practice

References

• Dodd GD 3rd, Soulen MC, Kane RA, Livraghi T, Lees WR, Yamashita Y, Gillams AR, Karahan OI, Rhim H. Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough. Radiographics 2000; 20: 9–27.
   Google Scholar
• Goldberg SN, Gazelle GS, Mueller PR. Thermal ablation therapy for focal malignancy: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. Am J Roentgenol 2000; 174: 323–31.
   Google Scholar
• Goldberg SN, Dupuy DE. Image-guided radiofrequency tumor ablation: challenges and opportunitiespart I. J Vase Int Radiat 2001; 12: 1020–32.
   Google Scholar
• Goldberg SN, Charboneau JW, Dodd GD 3rd, Dupuy DE, Gervais DA, Gillams AR, Kane RA, Lee FT Jr, Livraghi T, McGahan JP, Rhim H, Silverman SG, Solbiati L, Vogl Ti, Wood BJ. International working group on image-guided tumor ablation. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 2003; 228: 335–45.
   Google Scholar
• Vierra M. Minimally invasive surgery. Annu Rev Med 1995; 46: 147–58.
   PubMed Web of Science ®Google Scholar
• Bosch FX. Global epidemiology of hepatocellular carcinoma. In: Okuda K, Tabor E, eds. Liver cancer. New York: Churchill Livingstone, 1997; 13–28.
   Google Scholar
• Bosch X, Ribes J, Borras J. Epidemiology of primary liver cancer. Sernin Liver Dis 1999; 199: 271–85.
   Google Scholar
• Teo EK, Fock KM. Hepatocellular carcinoma: an Asian perspective. Dig Dis 2001; 19: 263–8.
   PubMed Web of Science ®Google Scholar
• Liu CL, Fan ST. Nonresectional therapies for hepatocellular carcinoma. Am J Surg 1997; 173: 358–65.
   PubMed Web of Science ®Google Scholar
• You WC, Jin F, Devesa S, Gridley G, Schatzkin A, Yang G, Rosenberg P, Xiang YB, Hu YR, Li Q. Rapid increase in colorectal cancer rates in urban Shanghai, 1972-97, in relation to dietary changes. J Cancer Epiderniol Prey 2002; 7: 143–6.
   PubMedGoogle Scholar
• Yang CX, Kuroishi T, Huang XE, Inoue M, Tajima K. Correlation between food consumption and colorectal cancer: an ecological analysis in Japan. Asian Pac J Cancer Prey 2002; 3: 77–83.
   Google Scholar
• Martin JK, O'Connell MJ, Wieand HS, Fitzgibbons RJ Jr, Mailliard JA, Rubin J, Nagorney DM, Tschetter LK, Krook JE. Intra-arterial floxuridine vs systemic fluorour-acil for hepatic metastases from colorectal cancer. Arch Surg 1990; 125: 1022–7.
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Keeffe EB. Screening for hepatocellular carcinoma. J Clin Gastroenterol 2002; 35: S86–91.
   PubMed Web of Science ®Google Scholar
• Unoura M, Kaneko S, Matsushita E, Shimoda A, Takeuchi M, Adachi H, et al. High-risk groups and screening strategies for early detection of hepatocellular carcinoma in patients with chronic liver disease. Hepatogastroenterology 1993; 40: 305–10.
   PubMedGoogle Scholar
• Larcos G, Sorokopud H, Berry G, Farrell GC. Sonographic screening for hepatocellular carcinoma in patients with chronic hepatitis or cirrhosis: an evaluation. Am J Roentgenol 1998; 171: 433–5.
   PubMed Web of Science ®Google Scholar
• Camma C, Schepis F, Orlando A, Albanese M, Shahied L, Trevisani F, Andreone P, Craxi A, Cottone M. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002; 224: 47–54.
   Google Scholar
• Ramsey DE, Kernagis LY, Soulen MC, Geschwind JF. Chemoembolization of hepatocellular arcinoma. J Vase Interv Radiol 2002; 13: S211–21.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Giorgio A. Mann G, Salmi A, de Sio I, Bolondi L, Pompili M, Brunello F, Lazzaroni S, Torzilli G. Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection. Radiology 1995; 197: 101–83.
   PubMed Web of Science ®Google Scholar
• Shiina S. Tagawa K, Niwa Y, Unuma T, Komatsu Y, Yoshiura K, Hamada E, Takahashi M, Shiratori Y, Terano A. Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients. Am J Roentgenol 1993; 160: 1023–8.
   Google Scholar
• Lau WY, Leung TW, Yu SC, Ho SK. Percutaneous local ablative therapy for hepato-cellular carcinoma: a review and look into the future. Ann Surg 2003; 237: 171–9.
   PubMed Web of Science ®Google Scholar
• Okada S. Local ablation therapy for hepatocellular carcinoma. Sernin Liver Dis 1999; 19: 323–8.
   PubMed Web of Science ®Google Scholar
• Liu LX, Zhang WH, Jiang HC. Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 2003; 9: 193–200.
   Google Scholar
• Poon RT, Fan ST, Tsang FH, Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002; 235: 466–86.
   PubMed Web of Science ®Google Scholar
• Ng KK, Lam CM, Poon RT, Ai V, Tso WK, Fan ST. Thermal ablative therapy for malignant liver tumors: a critical appraisal. J Gastroenterol Hepatol 2003; 18: 616–29.
   PubMed Web of Science ®Google Scholar
• Seki T, Wakabayashi M, Nakagawa T, Itho T, Shiro T, Kunieda K, Sato M, Uchiyama S, Inoue K. Ultrasonically guided percutaneous microwave coagulation therapy for small hepatocellular carcinoma. Cancer 1994; 74: 817–25.
   Google Scholar
• Seki T, Tamai T, Nakagawa T, Imamura M, Nishimura A, Yamashiki N, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma. Cancer 2000; 89: 1245–51.
   PubMed Web of Science ®Google Scholar
• Murakami R, Yoshimatsu S, Yamashita Y, Matsukawa T, Takahashi M, Sagara K. Treatment of hepatocellular carcinoma: value of percutaneous microwave coagulation. Arn J Roentgenol 1995; 164: 1159–64.
   PubMed Web of Science ®Google Scholar
• Dong BW, Zhang J, Liang P, Yu XL, Su L, Yu DJ, Su L, Yu DJ, Ji XL, Yu G. Sequential pathological and immunologic analysis of percutaneous microwave coagulation therapy of hepatocellular carcinoma. Int J Hypertherrnia 2003; 19: 119–33.
   PubMed Web of Science ®Google Scholar
• Lu MD, Chen JW, Xie XY, Liu L, Huang XQ, Liang II, Huang JF. Hepatocellular carcinoma: US-guided percutaneous microwave coagulation therapy. Radiology 2001; 221: 167–72.
   Google Scholar
• Shiina S, Teratani T, Obi S, Hamamura K, Koike Y, Omata M. Nonsurgical treatment of hepatocellular carcinoma: from percutaneous ethanol injection therapy and percutaneous microwave coagulation therapy to radiofrequency ablation. Oncology 2002; 62: 64–8.
   PubMed Web of Science ®Google Scholar
• Ishida T, Murakami T, Shibata T, Inoue Y, Takamura M, Niinobu T, Sato T, Nakamura H. Percutaneous microwave tumor coagulation for hepatocellular carcinomas with interruption of segmental hepatic blood flow. J Vase Interv Radiol 2002; 13: 185–91.
   PubMed Web of Science ®Google Scholar
• Shibata T, Iimuro Y, Yamamoto Y, Maetani Y, Ametani F, Itoh K, Konishi J. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology 2002; 223: 331–7.
   Google Scholar
• Rhim H. Current survey data for thermal ablation status in Asia. Int J Hypertherrnia 2004; in press.
   Google Scholar
• Choi D, Lim HK, Kim SH, Lee WJ, Jang Hi, Lee JY, Lee JY, Paik SW, Koh KC, Lee JH. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: usefulness of power Doppler US with a microbubble contrast agent in evaluating therapeutic response-preliminary results. Radiology 2000; 217: 558–63.
   PubMed Web of Science ®Google Scholar
• Choi D, Lim HK, Kim SH, Lee WJ, Jang Hi, Kim H, Lee Si, Lim JH. Assessment of therapeutic response in hepatocellular carcinoma treated with percutaneous radio fre-quency ablation: comparison of multiphase helical computed tomography and power Doppler ultrasonography with a microbubble contrast agent. J Ultrasound Med 2002; 21: 391–401.
   PubMed Web of Science ®Google Scholar
• Lim HK, Choi D, Lee WJ, Kim SH, Lee Si, Jang RI, et al. Hepatocellular carcinoma treated with percutaneous radio-frequency ablation: evaluation with follow-up multiphase helical CT. Radiology 2001; 221: 447–54.
   PubMed Web of Science ®Google Scholar
• Rhim H, Goldberg SN, Dodd GD 3rd, Solbiati L, Lim HK, Tonolini M, Cho OK. Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors. Radiographics 2001; 21: S17–35.
   Google Scholar
• Rhim H, Dodd GD 3rd. Radiofrequency thermal ablation of liver tumors. J Clin Ultrasound 1999; 27: 221–9.
   PubMed Web of Science ®Google Scholar
• Rhim H, Yoon KH, Lee JM, Cho Y, Cho is, Kim SH, Lee WJ, Lim HK, Nam GJ, Han SS, Kim YH, Park CM, Kim PN, Byun JY, et al. Major complications after radio-frequency thermal ablation of hepatic tumors. Radiographics 2003; 23: 123–34.
   PubMed Web of Science ®Google Scholar
• Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology 2003; 226: 441–51.
   PubMed Web of Science ®Google Scholar
• Yamakado K, Nakatsuka A, Ohmori S, Shiraki K, Nakano T, Ikoma J, et al. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vase Interv Radiol 2002; 13: 1225–32.
   PubMed Web of Science ®Google Scholar
• Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer 2003; 97: 1253–62.
   PubMed Web of Science ®Google Scholar
• Yamasaki T, Kurokawa F, Shirahashi H, Kusano N, Hironaka K, Okita K. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy. Cancer 2002; 95: 2353–60.
   Google Scholar
• Srivastava DN, Thulkar S, Sharma S, Pandey GK, Sahni P, Julka PK, et al. Therapeutic radiological interventional procedures in hepatocellular carcinoma. Indian J Gastroenterol 2002; 21: 96–8.
   PubMedGoogle Scholar
• Varshney S, Sharma S, Pamecha V, Sewkani A, Jhawar L, Narkhede V, et al. Radiofrequency tissue ablation: an early Indian experience. Indian J Gastroenterol 2003; 22: 91–3.
   PubMedGoogle Scholar
• Wang TH, Huang GT, Sheu JC, Daikuzono N, Sung JL, Chen DS. Laserthermia for the treatment of small hepatocellular carcinoma: a preliminary study. J Clin Laser Med Surg 1991; 9: 195–7.
   PubMedGoogle Scholar
• Zhou XD, Tang ZY, Yu YQ, Weng JM, Ma ZC, Zhang BH, Zheng YX. The role of cryosurgery in the treatment of hepatic cancer: a report of 113 cases. J Cancer Res Clin Oncol 1993; 120: 100–2.
   Google Scholar
• Gazelle GS, Goldberg SN, Solbiati L, Livraghi T. Tumor ablation with radiofrequency energy. Radiology 2000; 217: 6333–46.
   Web of Science ®Google Scholar
• Livraghi T. Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2003; 10: 67–76.
   PubMedGoogle Scholar
• Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepato-cellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology 1999; 210: 655–61.
   PubMed Web of Science ®Google Scholar
• Goldberg SN, Kamel IR, Kruskal .IB, Reynolds K, Monsky WL, Stuart KE, Ahmed M, Raptopoulos V. Radiofrequency ablation of hepatic tumors: increased tumor destruction with adjuvant liposomal doxorubicin therapy. Am J Roentgenol 2002; 179: 93–101.
   Google Scholar